Bayer Aktiengesellschaft (ETR:BAYN - Get Free Report) was down 4% during trading on Thursday . The stock traded as low as €21.17 ($23.01) and last traded at €21.43 ($23.29). Approximately 4,269,244 shares were traded during trading, The stock had previously closed at €22.32 ($24.26).
Bayer Aktiengesellschaft Trading Down 1.3 %
The company has a market capitalization of $20.02 billion, a price-to-earnings ratio of -22.75, a P/E/G ratio of 36.39 and a beta of 0.97. The business's 50 day moving average price is €22.39 and its two-hundred day moving average price is €22.65.
About Bayer Aktiengesellschaft
(
Get Free Report)
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
Recommended Stories
Before you consider Bayer Aktiengesellschaft, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bayer Aktiengesellschaft wasn't on the list.
While Bayer Aktiengesellschaft currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
